Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 152.85M
March 31, 2026 166.67M
December 31, 2025 185.90M
September 30, 2025 199.24M
June 30, 2025 209.83M
March 31, 2025 239.72M
December 31, 2024 236.41M
September 30, 2024 247.60M
June 30, 2024 283.45M
March 31, 2024 308.55M
December 31, 2023 316.22M
September 30, 2023 331.25M
June 30, 2023 320.21M
March 31, 2023 352.09M
Date Value
December 31, 2022 421.24M
September 30, 2022 436.06M
June 30, 2022 451.19M
March 31, 2022 445.23M
December 31, 2021 400.07M
September 30, 2021 506.60M
June 30, 2021 517.77M
March 31, 2021 531.14M
December 31, 2020 431.86M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 86.02M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. 4.358M
Medpace Holdings, Inc. 502.69M
Avantor, Inc. 306.80M
Personalis, Inc. 212.66M
Adaptive Biotechnologies Corp. 344.26M